Doseology Accelerates Rollout of Medicinal Mushroom Products with National Distribution
April 22, 2022
Ryan Allway April 22nd, 2022 Psychedelics, Top News VERNON, BC, April 22, 2022 /CNW/ — Doseology Sciences Inc.. (CSE: MOOD) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce it has signed a Distribution Agreement with Peak Performance Products Inc. (“Peak”)... Read more
Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms
May 25, 2021
Ryan Allway May 25th, 2021 Psychedelics DENVER, May 25, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced today... Read more
